ImpediMed Limited

OTC: IPDQF · Healthcare · Medical - Devices

PublicHQ Carlsbad, CA · San DiegoReports USD

#1 of 1,418 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 57

v0.1 · 5/100 weight · pillars only

↑ listing tenure, workforce scale · ↓ Altman-Z, Piotroski F

Methodology →

Revenue TTM

—

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

—

Employees

as of 2026-08-23

Market cap

$16.5M

as of 2026-08-23

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue—12.7M AUD2025

Net income—-23.2M AUD2025

Operating income—-24.2M AUD2025

Total assets—41.7M AUD2025

Liabilities—21.2M AUD2025

Equity—20.5M AUD2025

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is ImpediMed Limited’s financial profile?

ImpediMed Limited has no structured financials on file — private or non-XBRL filer.

Peers · Healthcare

Werewolf Therapeutics, Inc.——Cellectar Biosciences, Inc.——ProMIS Neurosciences, Inc.——Optimi Health Corp.——Akari Therapeutics, Plc——CS Diagnostics Corp.——

Neighbors

San Diego →

QUALCOMM Incorporated$44.3B79B+Realty Income Corporation$5.7B60C Sempra$12.4B64C DexCom, Inc.$4.7B87A ResMed Inc.$5.1B88A Illumina, Inc.$4.3B84B+

Key facts

CEOErik Anderson

SectorHealthcare

IndustryMedical - Devices

HeadquartersCarlsbad, CA

ExchangeOTC: IPDQF

Employees77

IPO date2012-09-25

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.